DOXORUBICINOL, THE METABOLITE OF DOXORUBUCIN, IS MORE CARDIOTOXIC THAN DOXORUBICIN

被引：13
|
作者：
BOUCEK, RJ
KUNKEL, EM
GRAHAM, TP
BRENNER, D
OLSON, RD
机构：
[1] VANDERBILT UNIV,MED CTR,SCH MED,DEPT PEDIAT,NASHVILLE,TN 37232
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BUFFALO,NY 14263
[3] VET ADM MED CTR,BOISE,ID
来源：
PEDIATRIC RESEARCH | 1987年 / 21卷 / 04期
关键词：
D O I：
10.1203/00006450-198704010-00127
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：A187 / A187
页数：1
相关论文
共 50 条
  • [1] DOXORUBICINOL - A MORE POTENT CARDIOTOXIN THAN DOXORUBICIN
    OLSON, RD
    BRENNER, DE
    MUSHLIN, PS
    BOERTH, RC
    HANDE, KR
    BOUCEK, RJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 227 - 227
  • [2] DOXORUBICIN CARDIOTOXICITY MAY BE CAUSED BY ITS METABOLITE, DOXORUBICINOL
    OLSON, RD
    MUSHLIN, PS
    BRENNER, DE
    FLEISCHER, S
    CUSACK, BJ
    CHANG, BK
    BOUCEK, RJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) : 3585 - 3589
  • [3] Metabolism of doxorubicin to the cardiotoxic metabolite doxorubicinol is increased in a mouse model of chronic glutathione deficiency: A potential role for carbonyl reductase 3
    Schaupp, Christopher M.
    White, Collin C.
    Merrill, Gary F.
    Kavanagh, Terrance J.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2015, 234 : 154 - 161
  • [4] Pegylated liposomal doxorubicin is less cardiotoxic than conventional doxorubicin
    Reactions Weekly, 1998, 718 (1) : 6 - 6
  • [5] EXOGENOUS DOXORUBICINOL INDUCES CARDIOTOXIC EFFECTS IN RATS
    DANESI, R
    DELTACCA, M
    BERNARDINI, C
    PENCO, S
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (07): : 907 - 913
  • [6] PHARMACOKINETICS OF DOXORUBICIN AND ITS METABOLITE DOXORUBICINOL IN RABBITS WITH INDUCED ACID AND ALKALINE URINE
    JOHANSEN, PB
    JENSEN, SE
    RASMUSSEN, SN
    DALMARK, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (01) : 5 - 8
  • [7] Carbonyl Reductase 1 Plays a Significant Role in Converting Doxorubicin to Cardiotoxic Doxorubicinol in Mouse Liver, but the Majority of the Doxorubicinol-Forming Activity Remains Unidentified
    Breysse, Daniel H.
    Boone, Ryan M.
    Long, Cameron M.
    Merrill, Miranda E.
    Schaupp, Christopher M.
    White, Collin C.
    Kavanagh, Terrance J.
    Schmidt, Edward E.
    Merrill, Gary F.
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (03) : 187 - 197
  • [8] DOXORUBICINOL - THE CULPRIT IN DOXORUBICIN CARDIOTOXICITY
    MUSHLIN, PS
    BOUCEK, RJ
    BRENNER, DE
    CUSACK, BJ
    FLEISCHER, S
    OLSON, RD
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 195 - 195
  • [9] DOXORUBICIN AND DOXORUBICINOL-INDUCED ALTERATIONS IN HUMAN POLYMORPHONUCLEAR LEUKOCYTE OXYGEN METABOLITE GENERATION
    NIELSON, CP
    BRENNER, D
    OLSON, RD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1986, 238 (01): : 19 - 25
  • [10] Simultaneous liquid chromatographic determination of doxorubicin and its major metabolite doxorubicinol in parrot plasma
    Gilbert, CM
    McGeary, RP
    Filippich, LJ
    Norris, RLG
    Charles, BG
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 826 (1-2): : 273 - 276
12345